TG-interacting factor (TGIF) is a transcriptional co-repressor that directly associates with Smad (Sma- and Mad-related protein) proteins and inhibits Smad-mediated transcriptional activation. By using Affymetrix (Santa Clara, CA, U.S.A.) oligonucleotide microarray analysis, we found that TGIF mRNA level was elevated by transforming-growth-factor-beta (TGF-beta) treatment in a human T-cell line, HuT78. Subsequent reverse-transcription PCR assays indicated that TGF-beta1 and activin were able to induce a rapid and transient increase in the level of TGIF in both HuT78 and HepG2 hepatoma cells. To analyse whether or not the regulation of TGIF mRNA occurs at the transcriptional level, a 2.4 kb human TGIF promoter was isolated. A primer extension assay was performed to localize the putative transcription initiation site of the promoter. When transiently expressed in HepG2 cells, this promoter was stimulated by TGF-beta1 and activin treatment in a time-dependent manner. A series of deletion mutants of the TGIF promoter were also generated to further characterize the TGF-beta responsive region of the promoter. In addition, expression of TGIF was able to cause a dose-dependent inhibition of TGF-beta and activin signalling. Taken together, these experiments indicated that TGIF is a novel transcriptional target of TGF-beta and activin signalling and is likely involved in a negative feedback loop to desensitize TGF-beta/activin action.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1223316 | PMC |
| http://dx.doi.org/10.1042/BJ20030095 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tgif1-deficiency impairs cytoskeletal architecture in osteoblasts by activating PAK3 signaling.
Elife
April 2024
Molecular Skeletal Biology Laboratory, Department of Trauma Surgery and Orthopedics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Article Synopsis
- Tgif1 deficiency in osteoblasts causes changes in cell shape, reduced ability to stick to collagen type I surfaces, and limits their movement.
- Tgif1 is crucial for maintaining normal osteoblast morphology and plays a role in regulating the interaction with collagen, affecting cell behavior in bone tissue.
- Its role as a transcriptional repressor of p21-activated kinase 3 impacts osteoblast spreading and recruitment during bone regeneration, especially when influenced by treatments like parathyroid hormone.
TG-interacting factor 1 regulates mitotic clonal expansion during adipocyte differentiation.
Biochim Biophys Acta Mol Cell Biol Lipids
June 2024
Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Electronic address:
Article Synopsis
- Obesity is a major global health issue linked to abnormal fat cell development, with TG-interacting factor 1 (TGIF1) playing a critical role in the differentiation of fat cells.
- Researchers used CRISPR/Cas9 technology to create preadipocytes lacking TGIF1, which showed no lipid accumulation, highlighting TGIF1's importance in fat cell formation.
- When TGIF1 was reintroduced in these cells, it spurred lipid accumulation through mechanisms like promoting cell division and regulating specific proteins, potentially offering insights into tackling obesity-related metabolic disorders.
Phosphorylation of TG-interacting factor 1 at carboxyl-terminal sites in response to insulin regulates adipocyte differentiation.
FEBS Lett
April 2024
Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
TG-interacting factor 1 (TGIF1) contributes to the differentiation of murine white preadipocyte and human adipose tissue-derived stem cells; however, its regulation is not well elucidated. Insulin is a component of the adipogenic cocktail that induces ERK signaling. TGIF1 phosphorylation and sustained stability in response to insulin were reduced through the use of specific MEK inhibitor U0126.
View Article and Find Full Text PDFPHRF1 Promotes Cell Invasion by Modulating SOX4 Expression in Colorectal Cancer HCT116-p53 Cells.
Anticancer Res
December 2023
Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan, R.O.C.;
Article Synopsis
- PHRF1 plays a critical role in enhancing TGF-β signaling in colorectal cancer by ubiquitinating TGIP and redistributing cPML.
- The study investigates the effects of knocking out PHRF1 in HCT116-p53 cells with Kras mutations, finding that while Zeb1 expression remains unchanged, SOX4 is essential for invasion.
- Results suggest that PHRF1 influences invasion via SOX4 modulation, providing new insights into the mechanisms of colorectal cancer invasion involving Kras mutations and p53 inactivation.
PHRF1 promotes the class switch recombination of IgA in CH12F3-2A cells.
PLoS One
August 2023
Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan.
PHRF1 is an E3 ligase that promotes TGF-β signaling by ubiquitinating a homeodomain repressor TG-interacting factor (TGIF). The suppression of PHRF1 activity by PML-RARα facilitates the progression of acute promyelocytic leukemia (APL). PHRF1 also contributes to non-homologous end-joining in response to DNA damage by linking H3K36me3 and NBS1 with DNA repair machinery.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!